Trigg Leslie insider trades
Trigg Leslie has filed 62 Form 4s with the SEC that we hold, for Outset Medical, Inc. (OM) (Chair and CEO, Director), EXAS (Director), Adaptive Biotechnologies Corp (ADPT) (Director) and ARYD (Director). Across all of them we count 0 purchases worth $0 and 70 sales worth $25.2M reported on Form 4. In the last 12 months: 0 purchases ($0) and 7 sales ($122.1K). The largest single trade was a sale of 30,000 shares of Outset Medical, Inc. worth $1.4M, dated 2022-04-01. The first filing on our record is dated 2021-07-02 and the latest 2026-08-18.
Outset Medical, Inc. (OM)
Chair and CEO, Director · 56 filings · 70 purchases and sales
| Trade date | Code | Shares | Value as filed | Filed | Source |
|---|---|---|---|---|---|
| 2021-07-01 | S, sale reported on Form 4 | 6,919 | $340.8K | 2021-07-02 | SEC |
| 2021-07-01 | S, sale reported on Form 4 | 13,081 | $644.2K | 2021-07-02 | SEC |
| 2021-07-01 | S, sale reported on Form 4 | 10,000 | $492.3K | 2021-07-02 | SEC |
| 2021-07-01 | S, sale reported on Form 4 | 12,500 | $615.6K | 2021-07-02 | SEC |
| 2021-08-02 | S, sale reported on Form 4 | 20,000 | $812.4K | 2021-08-03 | SEC |
| 2021-09-01 | S, sale reported on Form 4 | 5,000 | $245.8K | 2021-09-01 | SEC |
| 2021-09-01 | S, sale reported on Form 4 | 15,000 | $737.4K | 2021-09-01 | SEC |
| 2021-09-17 | S, sale reported on Form 4 | 15,000 | $825.0K | 2021-09-20 | SEC |
| 2021-10-01 | S, sale reported on Form 4 | 12,500 | $608.9K | 2021-10-04 | SEC |
| 2021-10-01 | S, sale reported on Form 4 | 20,000 | $973.8K | 2021-10-04 | SEC |
| 2021-10-01 | S, sale reported on Form 4 | 10,000 | $486.9K | 2021-10-04 | SEC |
| 2021-11-01 | S, sale reported on Form 4 | 15,000 | $825.0K | 2021-11-02 | SEC |
| 2021-11-01 | S, sale reported on Form 4 | 20,000 | $1.1M | 2021-11-02 | SEC |
| 2021-12-01 | S, sale reported on Form 4 | 14,373 | $679.0K | 2021-12-02 | SEC |
| 2021-12-01 | S, sale reported on Form 4 | 5,627 | $265.8K | 2021-12-02 | SEC |
| 2022-01-03 | S, sale reported on Form 4 | 10,000 | $470.9K | 2022-01-04 | SEC |
| 2022-01-03 | S, sale reported on Form 4 | 12,500 | $588.8K | 2022-01-04 | SEC |
| 2022-01-03 | S, sale reported on Form 4 | 20,000 | $942.0K | 2022-01-04 | SEC |
| 2022-02-01 | S, sale reported on Form 4 | 20,000 | $750.0K | 2022-02-03 | SEC |
| 2022-03-01 | S, sale reported on Form 4 | 20,000 | $869.8K | 2022-03-02 | SEC |
| 2022-03-16 | S, sale reported on Form 4 | 3,631 | $144.4K | 2022-03-16 | SEC |
| 2022-04-01 | S, sale reported on Form 4 | 20,000 | $923.6K | 2022-04-04 | SEC |
| 2022-04-01 | S, sale reported on Form 4 | 15,000 | $692.7K | 2022-04-04 | SEC |
| 2022-04-01 | S, sale reported on Form 4 | 30,000 | $1.4M | 2022-04-04 | SEC |
| 2022-05-02 | S, sale reported on Form 4 | 30,000 | $1.1M | 2022-05-03 | SEC |
| 2022-05-17 | S, sale reported on Form 4 | 909 | $24.0K | 2022-05-17 | SEC |
| 2022-06-01 | S, sale reported on Form 4 | 15,711 | $329.1K | 2022-06-02 | SEC |
| 2022-06-01 | S, sale reported on Form 4 | 14,289 | $299.4K | 2022-06-02 | SEC |
| 2022-08-01 | S, sale reported on Form 4 | 30,000 | $600.0K | 2022-08-02 | SEC |
| 2022-08-16 | S, sale reported on Form 4 | 914 | $19.6K | 2022-08-16 | SEC |
| 2022-11-11 | S, sale reported on Form 4 | 30,000 | $600.0K | 2022-11-14 | SEC |
| 2022-11-16 | S, sale reported on Form 4 | 916 | $17.7K | 2022-11-17 | SEC |
| 2022-12-01 | S, sale reported on Form 4 | 21,283 | $443.8K | 2022-12-02 | SEC |
| 2022-12-01 | S, sale reported on Form 4 | 8,717 | $181.7K | 2022-12-02 | SEC |
| 2023-01-03 | S, sale reported on Form 4 | 30,000 | $757.8K | 2023-01-04 | SEC |
| 2023-01-27 | S, sale reported on Form 4 | 6,281 | $175.4K | 2023-01-30 | SEC |
| 2023-02-01 | S, sale reported on Form 4 | 30,000 | $841.8K | 2023-02-02 | SEC |
| 2023-02-16 | S, sale reported on Form 4 | 932 | $22.7K | 2023-02-16 | SEC |
| 2023-02-16 | S, sale reported on Form 4 | 2,083 | $50.7K | 2023-02-16 | SEC |
| 2023-03-01 | S, sale reported on Form 4 | 30,000 | $674.4K | 2023-03-02 | SEC |
| 2023-05-03 | S, sale reported on Form 4 | 9,492 | $189.8K | 2023-05-05 | SEC |
| 2023-05-03 | S, sale reported on Form 4 | 10,508 | $210.2K | 2023-05-05 | SEC |
| 2023-05-03 | S, sale reported on Form 4 | 20,000 | $400.2K | 2023-05-05 | SEC |
| 2023-05-16 | S, sale reported on Form 4 | 2,962 | $59.0K | 2023-05-16 | SEC |
| 2023-06-01 | S, sale reported on Form 4 | 20,000 | $422.0K | 2023-06-01 | SEC |
| 2023-07-03 | S, sale reported on Form 4 | 20,000 | $418.0K | 2023-07-05 | SEC |
| 2023-08-01 | S, sale reported on Form 4 | 20,000 | $404.4K | 2023-08-03 | SEC |
| 2023-08-16 | S, sale reported on Form 4 | 3,028 | $45.7K | 2023-08-17 | SEC |
| 2023-11-16 | S, sale reported on Form 4 | 3,175 | $15.1K | 2023-11-17 | SEC |
| 2024-01-08 | S, sale reported on Form 4 | 14,188 | $77.9K | 2024-01-08 | SEC |
| 2024-01-16 | S, sale reported on Form 4 | 8,126 | $34.9K | 2024-01-17 | SEC |
| 2024-02-15 | S, sale reported on Form 4 | 5,320 | $19.0K | 2024-02-16 | SEC |
| 2024-05-16 | S, sale reported on Form 4 | 5,237 | $18.5K | 2024-05-17 | SEC |
| 2024-08-15 | S, sale reported on Form 4 | 5,308 | $4.5K | 2024-08-15 | SEC |
| 2024-11-15 | S, sale reported on Form 4 | 5,645 | $4.5K | 2024-11-18 | SEC |
| 2025-01-07 | S, sale reported on Form 4 | 10,227 | $13.2K | 2025-01-07 | SEC |
| 2025-01-13 | S, sale reported on Form 4 | 33,227 | $26.9K | 2025-01-13 | SEC |
| 2025-01-21 | S, sale reported on Form 4 | 18,449 | $14.8K | 2025-01-22 | SEC |
| 2025-01-21 | S, sale reported on Form 4 | 42,384 | $33.9K | 2025-01-22 | SEC |
| 2025-01-21 | S, sale reported on Form 4 | 4,403 | $3.5K | 2025-01-22 | SEC |
| 2025-02-18 | S, sale reported on Form 4 | 14,611 | $13.1K | 2025-02-19 | SEC |
| 2025-05-15 | S, sale reported on Form 4 | 935 | $16.6K | 2025-05-16 | SEC |
| 2025-08-15 | S, sale reported on Form 4 | 904 | $11.6K | 2025-08-18 | SEC |
| 2025-11-17 | S, sale reported on Form 4 | 916 | $4.2K | 2025-11-18 | SEC |
| 2026-01-07 | S, sale reported on Form 4 | 1,795 | $7.7K | 2026-01-08 | SEC |
| 2026-01-20 | S, sale reported on Form 4 | 11,794 | $60.4K | 2026-01-21 | SEC |
| 2026-01-21 | S, sale reported on Form 4 | 2,120 | $10.7K | 2026-01-21 | SEC |
| 2026-02-17 | S, sale reported on Form 4 | 3,361 | $11.3K | 2026-02-19 | SEC |
| 2026-05-15 | S, sale reported on Form 4 | 3,445 | $12.7K | 2026-05-19 | SEC |
| 2026-08-17 | S, sale reported on Form 4 | 3,437 | $15.1K | 2026-08-18 | SEC |
EXAS
Director · 3 filings · 0 purchases and sales
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Adaptive Biotechnologies Corp (ADPT)
Director · 2 filings · 0 purchases and sales
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
ARYD
Director · 1 filing · 0 purchases and sales
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Source
Counted from the Form 4 filings this reporting owner (SEC CIK 1304125) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
